NWS
ELV icon

Newport Wealth Strategies’s Elevance Health ELV Stock Holding History

Newport Wealth Strategies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$399K Hold
1,070
– – 0.24% 67
2021
Q2 		$409K Hold
1,070
– – 0.24% 72
2021
Q1 		$384K Sell
1,070
-50
-4% -$16.1K 0.24% 70
2020
Q4 		$301K Hold
1,120
– – 0.23% 64
2020
Q3 		$303K Hold
1,120
– – 0.23% 63
2020
Q2 		$295K Sell
1,120
-30
-3% -$8K 0.27% 58
2020
Q1 		$290K Buy
+1,150
New +$313K 0.27% 59

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Newport Wealth Strategies's ELV Position: Q3 2021 in Review

Newport Wealth Strategies held its Elevance Health (ELV) position steady in Q3 2021 at 1,070 shares worth $399K. The position accounts for 0.24% of the portfolio, ranked #67.

Newport Wealth Strategies first reported a position in ELV in Q1 2020 and has held it in 7 quarters since. The position peaked at $409K in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Newport Wealth Strategies held 1,070 shares of Elevance Health worth $399K as of Q3 2021.
  • Newport Wealth Strategies left its Elevance Health share count unchanged in Q3 2021.
  • Elevance Health made up 0.24% of Newport Wealth Strategies's portfolio in Q3 2021, its #67 holding.
  • Newport Wealth Strategies first reported a position in Elevance Health in Q1 2020 and has held it in 7 quarters since.
  • Newport Wealth Strategies's Elevance Health position peaked at $409K in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Newport Wealth Strategies's 13F filing for Q3 2021, filed 12 Nov 2021.